Industry Valuation and Performance
Has the Japanese Life Sciences Industry valuation changed over the past few years?
Date Market Cap Revenue Earnings PE Absolute PE PS Fri, 03 Feb 2023 JP¥297.3b JP¥172.1b JP¥14.2b 16x 21x 1.7x Sun, 01 Jan 2023 JP¥297.8b JP¥166.1b JP¥16.2b 15.3x 18.4x 1.8x Tue, 29 Nov 2022 JP¥332.5b JP¥165.5b JP¥16.0b 15.6x 20.8x 2x Thu, 27 Oct 2022 JP¥320.5b JP¥160.1b JP¥12.4b 16.2x 25.9x 2x Sat, 24 Sep 2022 JP¥314.6b JP¥160.1b JP¥12.4b 18.4x 25.4x 2x Mon, 22 Aug 2022 JP¥311.1b JP¥159.7b JP¥12.3b 18.8x 25.4x 1.9x Wed, 20 Jul 2022 JP¥293.1b JP¥152.8b JP¥10.9b 18.3x 26.9x 1.9x Fri, 17 Jun 2022 JP¥269.0b JP¥152.8b JP¥10.9b 17.2x 24.7x 1.8x Sun, 15 May 2022 JP¥232.8b JP¥152.7b JP¥11.3b 19.9x 20.5x 1.5x Tue, 12 Apr 2022 JP¥247.1b JP¥144.9b JP¥10.6b 21x 23.3x 1.7x Thu, 10 Mar 2022 JP¥228.5b JP¥144.7b JP¥10.6b 17.6x 21.6x 1.6x Sat, 05 Feb 2022 JP¥260.1b JP¥143.4b JP¥9.7b 22.8x 26.8x 1.8x Mon, 03 Jan 2022 JP¥284.1b JP¥136.0b JP¥6.8b 23.8x 42.1x 2.1x Wed, 01 Dec 2021 JP¥329.5b JP¥135.7b JP¥6.9b n/a 47.8x 2.4x Fri, 29 Oct 2021 JP¥396.4b JP¥198.8b JP¥8.1b 25.9x 49.1x 2x Sun, 26 Sep 2021 JP¥381.6b JP¥198.7b JP¥8.1b 25.9x 47.3x 1.9x Tue, 24 Aug 2021 JP¥351.1b JP¥201.8b JP¥5.0b 23.9x 69.6x 1.7x Wed, 30 Jun 2021 JP¥375.1b JP¥201.8b JP¥5.0b 26.2x 74.4x 1.9x Sat, 03 Apr 2021 JP¥301.1b JP¥193.8b JP¥2.3b 24.6x 128.3x 1.6x Tue, 05 Jan 2021 JP¥273.7b JP¥191.5b JP¥116.2m 26.7x 2355.1x 1.4x Fri, 09 Oct 2020 JP¥321.2b JP¥189.9b -JP¥496,535,000.00 55.3x -647x 1.7x Thu, 02 Jul 2020 JP¥327.4b JP¥189.7b JP¥2.0b 19.4x 162x 1.7x Sun, 05 Apr 2020 JP¥202.5b JP¥193.4b JP¥2.7b 18.1x 74x 1x 1Y 3Y 5Y 10Y Price to Earnings Price to Sales Median Price to Earnings Price to Earnings Ratio
Mon, 10 Feb 2020 Total Market Cap: JP¥254.9b Total Earnings: JP¥1.9b Total Revenue: JP¥190.2b Total Market Cap vs Earnings and Revenue 0% 0% 0% Japanese Life Sciences Industry Price to Earnings 3Y Average 169.9x 2021 2022 2023 Current Industry PE Investors are pessimistic on the Japanese Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically. The industry is trading at a PE ratio of 18.4x which is lower than its 3-year average PE of 170x. The industry is trading close to its 3-year average PS ratio of 1.7x. Past Earnings Growth The earnings for companies in the Life Sciences industry have grown 103% per year over the last three years. Meanwhile revenues for these companies have declined 4.4% per year. This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing. Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
7D 1M 3M 1Y 3Y 5Y JP Market -0.51% Healthcare -3.11% Life Sciences -0.013% Clinical Research and Equipment -0.013% Industry PEThere are no additional sub-industries under this industry. Forecasted GrowthThere are no additional sub-industries under this industry. Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
Simply Wall St ™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.